Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.345 USD | -0.45% |
|
-10.64% | +3.70% |
06-10 | William Blair Starts Tenaya Therapeutics With Outperform Rating | MT |
05-16 | Canaccord Genuity Adjusts Tenaya Therapeutics Price Target to $16 From $18, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.70% | 264M | |
+39.38% | 53.67B | |
+33.67% | 38.86B | |
-8.03% | 38.76B | |
-10.77% | 27.27B | |
+11.75% | 25.91B | |
-17.81% | 20.29B | |
+34.47% | 12.78B | |
+29.65% | 12.18B | |
-3.11% | 11.96B |
- Stock Market
- Equities
- TNYA Stock
- News Tenaya Therapeutics, Inc.
- Insider Buy: Tenaya Therapeutics